Deucravacitinib - Bristol-Myers Squibb
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Class Amides; Aniline compounds; Anti-inflammatories; Antipsoriatics; Antirheumatics; Cyclopropanes; Ethers; Hepatoprotectants; Organic deuterium compounds; Pyridazines; Skin disorder therapies; Small molecules; Triazoles; Urologics
- Mechanism of Action TYK2 kinase inhibitors
- USA Patent Applicants BRISTOL
- USA Patents 5
- NDAs 1
- International Patents 67
- Patent Applications 170
Table of Contents
Disclaimer